Digital Health

The leading organisation must be a NZ university, research organisation / institute, or Whānau Ora / Fonua Ola provider.

You can enter the pathway either at RAP Stage I or Stage II, however, to apply for RAP Stage III funding you must have successfully completed RAP Stage II.

Yes, you can apply for RAP Stage I and Stage II funding more than once, however it would require a strategy as to why you are coming back a second time, particularly for RAP Stage II.

For RAP Stage I and Stage II funding, you must have a collaboration of at least 2 organisations, with one of them being a member of the CMDT. For RAP Stage III, a single organisation can apply alone.

Yes, we do encourage international collaboration. Your international collaborators will need to bring their own funding to support their side of the project.

Te Tītoki Mataora | MedTech Research Translator has partnered with Health NZ | Te Whatu Ora, Whānau Tahi, and Moana Connect to propose the following three priority areas:

• Long-term conditions: Innovative solutions that address any stage along the pathway of long-term condition development, from early prevention through to enhanced care - for example, from early prevention of diabetes through to chronic kidney disease and transplant – that improve patients’ health or quality of life and/or minimise health system burden.

• Virtual/Digital hospital: Any technology solutions that will help move and support healthcare into the community.

• Whānau supporting whānau: Technology solutions that empower whānau to support each other in the prevention, diagnosis and management of COPD, Cardiovascular disease or Diabetes in their homes and communities.

RAP funding sits alongside Pre-Seed Accelerator Funding (PSAF) administered by KiwiNet and Return on Science. RAP funding typically supports concepts at a slightly earlier stage than PSAF which typically concentrates more on the commercial aspects of the project. However, RAP funded projects still need to consider their commercial pathway, although the emphasis is on technology and clinical validation to improve the success of projects when applying for PSAF and beyond.